Department of Medical Psychology, Amsterdam UMC, University of Amsterdam, Amsterdam Public Health, Amsterdam, the Netherlands.
Department of Medical Oncology, Cancer Center, University Medical Center Utrecht, Utrecht, the Netherlands.
Patient Educ Couns. 2021 Oct;104(10):2490-2497. doi: 10.1016/j.pec.2021.03.011. Epub 2021 Mar 9.
Providing a second opinion (SO) in oncology is complex, and communication during SOs remains poorly understood. This study aimed to systematically observe how patients and oncologists communicate about SO-specific topics (i.e., patient motivation, the referring oncologist, treatment transfer/back-referral), and how such communication affects patient satisfaction.
A prospective mixed-methods study of cancer patients seeking a SO (N = 69) and consulting oncologists was conducted. Before the SO, patients reported their expected place of future treatment. Following the SO, patients' and oncologists' satisfaction was assessed. All SOs were audio-recorded. Absolute and relative duration of SO-specific talk were calculated and specific events (e.g., questions/utterances) were coded (incl. valence, explicitness).
SOs lasted 19-73 min, of which 3.7% was spent discussing motivations. Oncologists rarely explored patients' motivations. Talk about referring oncologists (12.5% of consultation) was mostly critical by patients (M = 43.0%), but positive/confirming by consulting oncologists (M = 73.5%). Although 22.2% of patients expected a treatment transfer, this topic (3.3% of consultation time) was rarely explicitly discussed. Patients who were referred back were significantly less satisfied (d = 0.85).
Patient-provider communication in oncological SOs appears insufficiently aligned.
Patients and oncologists need support to explicitly and productively communicate about SO-specific topics and to better manage expectations. Recommendations are provided.
提供肿瘤学的第二意见(SO)较为复杂,且 SO 期间的沟通仍未得到充分理解。本研究旨在系统观察患者和肿瘤医生如何就 SO 特定主题(即患者动机、转诊医生、治疗转移/回诊)进行沟通,以及此类沟通如何影响患者满意度。
对寻求 SO 的癌症患者(N=69)和咨询肿瘤医生进行了前瞻性混合方法研究。在 SO 之前,患者报告了他们未来治疗的预期地点。在 SO 之后,评估了患者和肿瘤医生的满意度。所有 SO 均进行了录音。计算了 SO 特定谈话的绝对和相对持续时间,并对特定事件(例如问题/话语)进行了编码(包括语调、明确性)。
SO 持续 19-73 分钟,其中 3.7%用于讨论动机。肿瘤医生很少探讨患者的动机。关于转诊医生的讨论(咨询的 12.5%)主要是由患者提出的(M=43.0%),但由咨询肿瘤医生提出的(M=73.5%)是积极/确认的。尽管 22.2%的患者希望进行治疗转移,但这个话题(咨询时间的 3.3%)很少被明确讨论。被转回的患者满意度明显较低(d=0.85)。
肿瘤学 SO 中的医患沟通似乎没有充分协调。
患者和肿瘤医生需要支持,以便就 SO 特定主题进行明确和富有成效的沟通,并更好地管理预期。提供了相关建议。